Tver State Medical University is a research, scientific and educational center.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
4
Supergene, LLC
4
Actelion
2
Boehringer Ingelheim
1
Hospital do Coracao
1
Clinical Trials at Tver Regional Clinical Hospital
During the past decade, Tver Regional Clinical Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on
average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler
2018-08-15
2019-10-04
Completed
4,819
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Tver Regional Clinical Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Supergene, LLC" with 4 trials
sponsored, "Actelion" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Hospital do Coracao"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Tver Regional Clinical Hospital
According to Clinical.Site data, the most researched conditions in "Tver Regional Clinical Hospital" are
"Arthritis, Psoriatic" (2 trials), "Acute Limb Ischemia" (1 trials), "Acute ST Segment Elevation Myocardial Infarction" (1 trials), "Colitis, Ulcerative" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Tver Regional Clinical Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Tver Regional Clinical Hospital
Most popular intervention types in "Tver Regional Clinical Hospital" are "Drug" (12 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Alteplase" (2 trials), "Guselkumab" (2 trials), "Recombinant staphylokinase" (2 trials) and "Canagliflozin 100 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Tver Regional Clinical Hospital
The vast majority of trials in "Tver Regional Clinical Hospital" are
12 trials for "All" genders.
Clinical Trials Status at Tver Regional Clinical Hospital
Currently, there are NaN active trials in "Tver Regional Clinical Hospital".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Tver Regional Clinical Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tver Regional Clinical Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".